Atossa Therapeutics, Inc. (ATOS)
5.365
+0.26
(+4.99%)
USD |
NASDAQ |
Apr 02, 16:00
5.36
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics Market Cap : 48.46M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Celldex Therapeutics, Inc. | 2.067B |
| Plus Therapeutics, Inc. | 22.33M |
| Abeona Therapeutics, Inc. | 289.99M |
| Cell Source, Inc. | 36.03M |
| Kiora Pharmaceuticals, Inc. | 7.507M |
Market Cap Related Metrics
| PEG Ratio | -0.0061 |
| Price to Book Value | 1.174 |
| Price | 5.365 |
| Earnings Yield | -61.69% |
| PEGY Ratio | -0.0061 |